NFKB1 and neoplasm: Consistently, although functional analysis demonstrated the enrichment of anti-tumor pathways, including T-cell activation, and TNF- and NF-κB signaling pathways in T cells from SC models, they also exhibited significant enrichment in pro-tumor IL-17 signaling pathways (Fig. 2G).